BSE: BIOCON - Biocon Limited

छह महीने के लिए लाभप्रदता: +5.38%
भाग प्रतिफल: +0.42%

पदोन्नति कार्यक्रम Biocon Limited


कंपनी के बारे में Biocon Limited

Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services.

अधिक जानकारी
The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.

ISIN INE376G01013
Industry Biotechnology
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.4195
Дивиденд ао 0.5
Сайт https://www.biocon.com
Цена ао 364.8
प्रति दिन मूल्य परिवर्तन: +2.1% (364.8)
प्रति सप्ताह मूल्य परिवर्तन: -2.59% (382.35)
प्रति माह मूल्य परिवर्तन: +5.6% (352.7)
3 महीने में कीमत में बदलाव: +5.69% (352.4)
छह महीने में कीमत में बदलाव: +5.38% (353.45)
प्रति वर्ष मूल्य परिवर्तन: +32.57% (280.95)
3 वर्षों में मूल्य परिवर्तन: +3.47% (359.95)
5 वर्षों में मूल्य परिवर्तन: +30.25% (285.95)
10 वर्षों में मूल्य परिवर्तन: 0% (372.45)
वर्ष की शुरुआत से मूल्य परिवर्तन: +2.1% (364.8)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 2.13 7
P/BV 1.19 9
P/E 29.51 6
EV/EBITDA 16.97 6
कुल: 7

क्षमता

नाम अर्थ श्रेणी
ROA, % 1.89 1
ROE, % 5.43 2
कुल: 2.17

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0.4195 1.05
DSI 0.9286 9.29
कुल: 2.2

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA 6.48 0
कुल: 3.4

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 125.31 10
लाभप्रदता Ebitda, % 40.16 6
लाभप्रदता EPS, % 37.03 5
कुल: 5.2

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
iShares MSCI India Small-Cap ETF 0.44091 0.4625 0.96163
iShares MSCI Emerging Markets Small-Cap ETF 0.13861 7.67 2.7853
Franklin FTSE India ETF 0.11361 20.52 1.25133
WisdomTree India Earnings Fund 0.03674 5.23 1.65591
JPMorgan ActiveBuilders Emerging Markets Equity ETF 0.03636 9.27 3.1658
SPDR Portfolio Emerging Markets ETF 0.02908 11.59 3.1879
Avantis Responsible Emerging Markets Equity ETF 0.0279 17.6 3.1719
Franklin FTSE Asia ex Japan ETF 0.02659 14.43 2.66768
Dimensional Emerging Markets Value ETF 0.01912 17.07 4.19508
John Hancock Multifactor Emerging Markets ETF 0.01141 4.68 3.42078
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01046 12.46 3.59676
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.01012 2.43 4.35382
Vanguard ESG International Stock ETF 0.01 6.39 3.07501
iShares Core MSCI Total International Stock ETF 0.00917 6.4 3.25258
Avantis Emerging Markets Equity ETF 0.00884 8.77 3.60513
Dimensional Emerging Markets Core Equity 2 ETF 0.00859 15.96 3.34087
Dimensional World ex U.S. Core Equity 2 ETF 0.00222 13.06 3.62488

पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Siddharth Mittal BCom, CA, CPA MD, CEO & Director 47.88M 1978 (47 साल)
Mr. Saurabh Paliwal Head of Investor Relations N/A
Mr. Mayank Verma Company Secretary & Compliance Officer 5.75M
Ms. Seema Shah Ahuja BA, MBA Global Head of Communications & Corporate Brand N/A 1966 (59 साल)
Mr. Peter James Jonathan Bains Group Chief Executive Officer 3.28M 1957 (68 साल)
Mr. Arun Gupta Head of Operations N/A
Mr. Atanu Roy Group Chief Information Officer N/A
Ms. Maninder Kapoor Puri Head of Human Resources N/A 1973 (52 वर्ष)
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc. Founder & Executive Chairperson 1953 (72 वर्ष)
Mr. Mukesh Kamath Chief Financial Officer

पता: India, Bengaluru, 20th KM Hosur Road - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.biocon.com